metoprolol has been researched along with Hypertension, Renal in 15 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
Hypertension, Renal: Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| "An interim analysis of the AASK trial at three years demonstrates a renoprotective effect [slower decline in glomerular filtration rate (GFR), delayed onset of significant decrease in GFR, end-stage renal disease (ESRD) or death, and a decrease in urinary protein excretion] of the angiotensin converting enzyme (ACE) inhibitor, ramipril, as compared to the dihydropyridine calcium channel blocker (DHP-CCB), amlodipine, in patients with mild-to-moderate renal insufficiency." | 5.10 | ACE inhibition is effective and renoprotective in hypertensive nephrosclerosis: the African American Study of Kidney Disease and Hypertension (AASK) trial. ( Agodoa, L; Douglas, JG, 2003) |
| " This study explores the association between G-protein-coupled receptor kinase type 4 (GRK4) variants and blood pressure response to metoprolol among African Americans with early hypertensive nephrosclerosis." | 3.75 | G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions. ( Appel, LJ; Bakris, GL; Bhatnagar, V; Brophy, VH; Contreras, G; Hiremath, L; Lipkowitz, MS; Middleton, JP; Nievergelt, CM; Norris, KC; O'Connor, DT; Richard, E; Salem, RM; Schork, NJ; Wright, J, 2009) |
| "Treatment with indapamide was followed by a significant decrease of plasma adiponectin concentration." | 2.73 | Indapamide decreases plasma adiponectin concentration in patients with essential hypertension. ( Adamczak, M; Chudek, J; Piecha, G; Wiecek, A, 2007) |
| "Ramipril treatment was associated with a significantly lower risk of DM in African Americans with hypertensive kidney disease than amlodipine or metoprolol treatment." | 1.33 | Differing effects of antihypertensive drugs on the incidence of diabetes mellitus among patients with hypertensive kidney disease. ( Agodoa, LY; Appel, LJ; Cheek, D; Contreras, G; Gassman, J; Lash, JP; Miller, ER; Randall, OS; Thornley-Brown, D; Wang, X; Wright, JT, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (40.00) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhatnagar, V | 1 |
| O'Connor, DT | 1 |
| Brophy, VH | 1 |
| Schork, NJ | 1 |
| Richard, E | 1 |
| Salem, RM | 1 |
| Nievergelt, CM | 1 |
| Bakris, GL | 1 |
| Middleton, JP | 1 |
| Norris, KC | 1 |
| Wright, J | 1 |
| Hiremath, L | 1 |
| Contreras, G | 2 |
| Appel, LJ | 2 |
| Lipkowitz, MS | 1 |
| Liesemer, K | 1 |
| Mullen, N | 1 |
| Douglas, JG | 1 |
| Agodoa, L | 1 |
| Thornley-Brown, D | 1 |
| Wang, X | 1 |
| Wright, JT | 1 |
| Randall, OS | 1 |
| Miller, ER | 1 |
| Lash, JP | 1 |
| Gassman, J | 1 |
| Agodoa, LY | 1 |
| Cheek, D | 1 |
| Piecha, G | 1 |
| Adamczak, M | 1 |
| Chudek, J | 1 |
| Wiecek, A | 1 |
| James, DW | 1 |
| Cleland, LG | 1 |
| Robinson, CW | 1 |
| Leonello, PP | 1 |
| Lameyer, LD | 1 |
| Hesse, CJ | 1 |
| Leeman, M | 1 |
| Vereerstraeten, P | 1 |
| Uytdenhoef, M | 1 |
| Degaute, JP | 1 |
| McConaghy, JR | 1 |
| de Fremont, JF | 1 |
| Coevoet, B | 1 |
| Andrejak, M | 1 |
| Makdassi, R | 1 |
| Quichaud, J | 1 |
| Lambrey, G | 1 |
| Gueris, J | 1 |
| Caillens, C | 1 |
| Harichaux, P | 1 |
| Alexandre, JM | 1 |
| Fournier, A | 1 |
| Yeo, WW | 1 |
| Ramsay, LE | 1 |
| Jackson, PR | 1 |
| Kirby, DA | 1 |
| Pinto, JM | 1 |
| Lown, B | 1 |
| McKenna, F | 1 |
| Davison, AM | 1 |
| Huysmans, FT | 1 |
| van Heusden, FH | 1 |
| Wetzels, JF | 1 |
| Hoitsma, AJ | 1 |
| Koene, RA | 1 |
| Yasumoto, R | 1 |
| Asakawa, M | 1 |
| Kakinoki, K | 1 |
| Umeda, M | 1 |
| Yoshimoto, M | 1 |
| Kawashima, H | 1 |
| Tanabe, S | 1 |
| Nishisaka, N | 1 |
| Kishimoto, T | 1 |
6 trials available for metoprolol and Hypertension, Renal
| Article | Year |
|---|---|
ACE inhibition is effective and renoprotective in hypertensive nephrosclerosis: the African American Study of Kidney Disease and Hypertension (AASK) trial.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Black or African | 2003 |
Indapamide decreases plasma adiponectin concentration in patients with essential hypertension.
Topics: Adiponectin; Adult; Amlodipine; Antihypertensive Agents; Blood Pressure; Enalapril; Female; Glomerul | 2007 |
Metoprolol in high renin hypertension. A comparison with propranolol.
Topics: Adult; Clinical Trials as Topic; Female; Glomerular Filtration Rate; Humans; Hypertension; Hypertens | 1981 |
Systemic and renal hemodynamic responses to carvedilol and metoprolol in hypertensive renal transplant patients.
Topics: Adrenergic beta-Antagonists; Adult; Carbazoles; Carvedilol; Double-Blind Method; Female; Glomerular | 1993 |
What is the best treatment for slowing the progression to end-stage renal disease (ESRD) in African Americans with hypertensive nephropathy?
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Black People; Double-Blind Method; Female; Glomeru | 2001 |
Renin and beta-blockade: prorenin and aldosterone may explain the controversy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aldosterone; Blood Pressure; Clinical Trials as Topic; Dou | 1986 |
9 other studies available for metoprolol and Hypertension, Renal
| Article | Year |
|---|---|
G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions.
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Black or African American; Blood Pressur | 2009 |
Hypertensive emergency successfully treated with metoprolol: a case report.
Topics: Acute Disease; Adrenergic beta-Antagonists; Cerebral Palsy; Child; Developmental Disabilities; Emerg | 2009 |
Differing effects of antihypertensive drugs on the incidence of diabetes mellitus among patients with hypertensive kidney disease.
Topics: Adrenergic beta-Antagonists; Adult; Amlodipine; Antihypertensive Agents; Black or African American; | 2006 |
Reversible renal failure: associated with treatment with a beta-adrenergic receptor blocking drug and non-steroidal anti-inflammatory drugs.
Topics: Acute Kidney Injury; Adrenergic beta-Antagonists; Anti-Inflammatory Agents; Arthritis, Rheumatoid; C | 1982 |
Effects of antihypertensive drugs on dialysis-resistant hypertension, plasma renin and dopamine betahydroxylase activities, metabolic risk factors and calcium phosphate homeostasis: comparison of metoprolol, alphamethyldopa and clonidine in a cross-over t
Topics: Clonidine; Dopamine beta-Hydroxylase; Humans; Hypertension, Renal; Kidney Failure, Chronic; Methyldo | 1979 |
Renal protective effect of enalapril in diabetic nephropathy.
Topics: Diabetic Nephropathies; Enalapril; Humans; Hypertension, Renal; Metoprolol | 1992 |
Changes in ventricular fibrillation threshold during the development of perinephritic hypertension.
Topics: Animals; Atropine; Blood Pressure; Cardiac Pacing, Artificial; Cardiomegaly; Dogs; Electrophysiology | 1990 |
Antihypertensive effect of beta blockade in renal transplant recipients with or without host kidneys.
Topics: Adrenergic beta-Antagonists; Angiotensins; Atenolol; Humans; Hypertension, Renal; Kidney; Kidney Tra | 1988 |
[Effect of metoprolol in patients with renal hypertension].
Topics: Adult; Aged; Blood Pressure; Drug Evaluation; Female; Humans; Hypertension, Renal; Kidney; Male; Met | 1988 |